Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia-a real-world analysis of the Polish Adult Leukemia Study Group

Sobon, A; Drozd-Sokolowska, J; Paszkiewicz-Kozik, E; Poplawska, L; Morawska, M; Tryc-Szponder, J; Bolkun, L; Rybka, J; Pruszczyk, K; Juda, A; Majeranowski, A; Iskierka-Jazdzewska, E; Steckiewicz, P; Wdowiak, K; Budziszewska, B; Jamroziak, K; Hus, I; Lech-Maranda, E; Pula, B

Pula, B (通讯作者)，Inst Hematol & Transfus Med, Dept Hematol, Indira Gandhi Str 14, PL-02776 Warsaw, Poland.

ANNALS OF HEMATOLOGY, 2023; 102 (8): 2119

Abstract

The results of the MURANO trial showed encouraging progression-free survival (PFS) and overall survival (OS) in relapsed/refractory chronic lymphocyti......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索